Combining a noble gas with radiotherapy: glutamate receptor antagonist xenon may act as a radiosensitizer in glioblastoma.
Thomas BüttnerMarielena K E MaerevoetFrank A GiordanoMarlon R VeldwijkCarsten HerskindArne Mathias Ruder
Published in: Radiation oncology (London, England) (2024)
The developed system allows for testing of gaseous agents with CFA. As a proof of concept, we have, for the first time, unveiled indications of radiosensitizing properties of xenon gas in glioblastoma.